Abstract
Specific peptides derived from the cytotoxicity receptor natural killer protein 44 (NKp44) useful for treating diseases such as cancer are described. The invention further relates to compositions comprising a fragment of the extracellular region of NKp44 for preventing or treating cancer.
| Original language | English |
|---|---|
| Patent number | US9399667B2 |
| State | Published - 1 Jul 2016 |